{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:50:12Z","timestamp":1782190212148,"version":"3.54.5"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK139356, 1R01DK118278-01."],"award-info":[{"award-number":["R01DK139356, 1R01DK118278-01."]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001167","name":"Larry L. Hillblom Foundation","doi-asserted-by":"publisher","award":["Network Grant"],"award-info":[{"award-number":["Network Grant"]}],"id":[{"id":"10.13039\/100001167","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Clin. Diabetes Healthc."],"abstract":"<jats:p>Type 2 diabetes mellitus (T2DM), marked by insulin resistance and impaired blood glucose regulation, can lead to serious complications when poorly controlled. Recent studies highlight interactions between diet, sleep, and metabolic disorders, showing that elevated nighttime glucose levels are associated with a higher risk of cardiometabolic disorders. Time-restricted eating (TRE) is a lifestyle strategy that aligns dietary intake with the circadian system with a consistent 8- to 10-hour eating window during the day. TRE is a safe and effective lifestyle intervention that improves cardiovascular health and glycemic control, and may provide additional benefits beyond stable use of a glucagon-like peptide-1 receptor agonist (GLP-1RA). The three patients presented here participated in a clinical trial for adults with T2DM in which they were instructed to follow a consistent 8 to 10-hour TRE intervention for 3 months (NCT05365529). Assessments, including fasted blood draws, 10-day continuous glucose monitor (CGM) use, and 14-day actigraphy to measure sleep-wake cycles, were conducted at baseline and 3 months. At baseline, all 3 patients were on stable GLP-1RA and exhibited high mean glucose levels (&amp;gt;130mg\/dL) during their nightly sleep. Following the 3-month TRE intervention, all 3 patients experienced reductions in hemoglobin A1c (HbA1c) and nighttime glucose, along with improved time in range (TIR) during sleep. This case series highlights the potential benefits of TRE, alongside GLP-1RA use, on nighttime glucose levels, while also underscoring the potential of CGM to identify glycemic phenotypes that may predict specific responses to TRE, demonstrating the importance of a personalized approach.<\/jats:p>","DOI":"10.3389\/fcdhc.2026.1725278","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:29:59Z","timestamp":1782188999000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Time-restricted eating in adults with type 2 diabetes mellitus on concomitant glucagon-like peptide-1 receptor agonists: case report"],"prefix":"10.3389","volume":"7","author":[{"given":"Kyla L.","family":"Laing","sequence":"first","affiliation":[{"name":"Regulatory Biology, Salk Institute for Biological Studies","place":["La Jolla, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan L.","family":"Levy","sequence":"additional","affiliation":[{"name":"Regulatory Biology, Salk Institute for Biological Studies","place":["La Jolla, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Wilkinson","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, University of California, San Diego","place":["San Diego, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Varshney","sequence":"additional","affiliation":[{"name":"Regulatory Biology, Salk Institute for Biological Studies","place":["La Jolla, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satchidananda","family":"Panda","sequence":"additional","affiliation":[{"name":"Regulatory Biology, Salk Institute for Biological Studies","place":["La Jolla, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam R.","family":"Taub","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, University of California, San Diego","place":["San Diego, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily N. C.","family":"Manoogian","sequence":"additional","affiliation":[{"name":"Regulatory Biology, Salk Institute for Biological Studies","place":["La Jolla, CA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"B1","unstructured":"National diabetes statistics report 2026\n          \n          2026"},{"key":"B2","unstructured":"The diabetes atlas 2025\n          \n          2025"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-020-0278-5","article-title":"Genetics of diabetes mellitus and diabetes complications","volume":"16","author":"Cole","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2337\/dci23-0085","article-title":"Economic costs of diabetes in the U.S. in 2022","volume":"47","author":"Parker","year":"2024","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2337\/dci24-0003","article-title":"Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity","volume":"47","author":"Drucker","year":"2024","journal-title":"Diabetes Care"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7326\/m24-0859","article-title":"Time-restricted eating in adults with metabolic syndrome : a randomized controlled trial","author":"Manoogian","year":"2024","journal-title":"Ann Intern Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2005143","article-title":"Glucotypes reveal new patterns of glucose dysregulation","volume":"16","author":"Hall","year":"2018","journal-title":"PloS Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.34133\/2022\/9892340","article-title":"Stratification of patients with diabetes using continuous glucose monitoring profiles and machine learning","volume":"2022","author":"Mao","year":"2022","journal-title":"Health Data Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1016\/j.cmet.2022.09.007","article-title":"Late isocaloric eating increases hunger, decreases energy expenditure, and modifies metabolic pathways in adults with overweight and obesity","volume":"34","author":"Vujovi\u0107","year":"2022","journal-title":"Cell Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1161\/cir.0000000000000476","article-title":"Meal timing and frequency: implications for cardiovascular disease prevention: a scientific statement from the American Heart Association","volume":"135","author":"St-Onge","year":"2017","journal-title":"Circulation"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abg9910","article-title":"Daytime eating prevents internal circadian misalignment and glucose intolerance in night work","volume":"7","author":"Chellappa","year":"2021","journal-title":"Sci Adv"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1007824","article-title":"The impact of a self-selected time restricted eating intervention on eating patterns, sleep, and late-night eating in individuals with obesity","volume":"9","author":"Simon","year":"2022","journal-title":"Front Nutr"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41366-021-01038-3","article-title":"Assessing temporal eating pattern in free living humans through the myCircadianClock app","author":"Manoogian","year":"2022","journal-title":"Int J Obes (Lond)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/19322968211028909","article-title":"A new analysis tool for continuous glucose monitor data","volume":"16","author":"Olawsky","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.26463\/rjms.15_1_12","article-title":"Glycemic goals and hypoglycemia: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"B16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.metabol.2017.11.017","article-title":"Circadian regulation of glucose, lipid, and energy metabolism in humans","volume":"84","author":"Poggiogalle","year":"2018","journal-title":"Metabolism"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2017.04.003","article-title":"Late dinner impairs glucose tolerance in MTNR1B risk allele carriers: a randomized, cross-over study","volume":"37","author":"Lopez-Minguez","year":"2018","journal-title":"Clin Nutr"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2010.09.001","article-title":"New evidence for a role of melatonin in glucose regulation","volume":"24","author":"Peschke","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3778","article-title":"Chrononutrition in type 2 diabetes mellitus and obesity: a narrative review","volume":"40","author":"Verde","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-05059-6","article-title":"Impact of circadian disruption on glucose metabolism: implications for type 2 diabetes","volume":"63","author":"Mason","year":"2020","journal-title":"Diabetologia"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0115","article-title":"Isn't this just bedtime snacking? The potential adverse effects of night-eating symptoms on treatment adherence and outcomes in patients with diabetes","volume":"29","author":"Morse","year":"2006","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2023.101788","article-title":"The interrelationship between sleep, diet, and glucose metabolism","volume":"69","author":"St-Onge","year":"2023","journal-title":"Sleep Med Rev"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2012.12.006","article-title":"Nighttime blood pressure, nighttime glucose values, and target-organ damages in treated type 2 diabetes patients","volume":"227","author":"Yano","year":"2013","journal-title":"Atherosclerosis"}],"container-title":["Frontiers in Clinical Diabetes and Healthcare"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2026.1725278\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:30:26Z","timestamp":1782189026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcdhc.2026.1725278\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":23,"alternative-id":["10.3389\/fcdhc.2026.1725278"],"URL":"https:\/\/doi.org\/10.3389\/fcdhc.2026.1725278","relation":{},"ISSN":["2673-6616"],"issn-type":[{"value":"2673-6616","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"article-number":"1725278"}}